Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128969 · ClinicalTrials.gov registry record · Phase 2
Causal Mechanisms in Adolescent Arterial Stiffness
A Phase 2 study of Metabolic Syndrome and Pediatric Obesity, sponsored by Baylor College of Medicine.
- Active
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04128969 is a Phase 2 study of Metabolic Syndrome and Pediatric Obesity that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 90 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04128969, a Phase 2 study of Metabolic Syndrome and Pediatric Obesity, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Hardening of the blood vessels, called arterial stiffness, is a risk factor for future heart disease and its causes are unclear. The proposed study will 1) randomly assign adolescents at high risk of stiffening blood vessels to take a protein supplement called carnitine and study its effects on arterial stiffening and 2) study carnitine related genes for their effect on arterial stiffening. The study will definitively establish a role for carnitine action as a cause of stiffening blood vessels and signal a way to treat or prevent stiffening.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT CS+
- DIETARY_SUPPLEMENT CS-
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2026-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04128969
The ClinicalTrials.gov registry entry for NCT04128969 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (93% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 2 interventions - of which CS+ is the first listed.
NCT04128969 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04128969 about?
NCT04128969 is a clinical study titled "Causal Mechanisms in Adolescent Arterial Stiffness". Hardening of the blood vessels, called arterial stiffness, is a risk factor for future heart disease and its causes are unclear. The proposed study will 1) randomly assign adolescents at high risk of stiffening blood vessels to take a protein supplement called carnitine and study its effects on arte...
What is the current status of trial NCT04128969?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2020-02-01. Estimated completion is 2026-08-31.
What conditions does trial NCT04128969 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Pediatric Obesity, Dyslipidemias, Lipid Disorder, Insulin Resistance Syndrome.
What interventions are being tested in trial NCT04128969?
The interventions under investigation include: CS+ (DIETARY_SUPPLEMENT), CS- (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04128969?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04128969 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Combined Oral Contraceptive Pill and Resistance Starch
RECRUITING · Phase 2
-
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
RECRUITING · Phase 2
-
Metformin in Kidney Disease
COMPLETED · Phase 2
-
The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome
COMPLETED · Phase 2
-
Effects of Human Leptin Replacement
COMPLETED · Phase 2
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.